C4x Discovery Share Discussion Threads

[amaretto1] 10/4/2020 10:01

When u start paying ADVFN .. then spout !

[alloa2003] 10/4/2020 09:23

Is this suddenly the INDV board? An update is fine but a constant ramble is over the top.

[the stigologist] 10/4/2020 06:46

Fair enough

[amaretto1] 10/4/2020 06:15

Also Net Cash since last update, which was not so long ago..Has already dropped another 150 million !! INDV I'll shut up now forever on the above.

[amaretto1] 09/4/2020 18:01

All I'm saying INDV are not going under... but will need cash, to go forward .. which will dilute current share holders. Above is what I've been told by pharma guru at MS.

[amaretto1] 09/4/2020 17:31

Listen .. indv will eat thru that cash pile ... never mind the pay off to USA Explain to me what's not true ??

[amaretto1] 09/4/2020 17:28

I'm being told they will have to come to market for cash All products .. have falling sales.. This drug collaboration with C4X might be the company saver.And why the hell is Cx4 trading at this ridiculous low valuation. Nuts !!

[the stigologist] 09/4/2020 17:24

have you ever stopped drinking dude ?

[davemac3] 09/4/2020 15:46

from INDV board

amaretto18 Apr '20 - 11:41 - 2587 of 2591
0 0 0
im out talked to my guru
she says sell veiled profits warning
sorry did have faith
invested else were, good look longs
cx4d far morew potencial lost 20k for now.


plonker

[amaretto1] 08/4/2020 13:55

I've sold out ... far 2 risky !

[the stigologist] 08/4/2020 09:18

Thoughts on INDV news

Just highlights the now massive game changing importance of C4XD Orexin antagonist INDV2000 to future of INDV now

From a Lawsuit perspective it's a nice cheeky : "hey even if you win we might already be bankrupt"

DoJ might say do we want to risk wiping out INDV employees during a Recession / Plague ?

Clever.

[the stigologist] 07/4/2020 09:20

Come on C4XD lets have news you're sitting on

[amaretto1] 06/4/2020 19:28

Director has strong money in here... must be confident.

[davemac3] 06/4/2020 09:39

A NRF-2 agonist candidate has not been identified yet, so I doubt it.

[the stigologist] 04/4/2020 21:19

My reading of this is that Lifearc an existing C4XD partner would look favourably at C4XD asking for COVID19 funding to advance our NRF2 agonist candidate?

[the stigologist] 03/4/2020 14:37

Was just looking through ETX Annual Report... they mention C4X alongside Novo Nordisk and Merck !

[the stigologist] 02/4/2020 21:52

Anyway I went back and watched INDV recent results webcast. They expect INDV2000 trial to start in Q2 so we should get news relating to that soon

Quite clear it is the BIGGIE in their development pipeline

[timberwolf3] 02/4/2020 19:06

Well the deal SLN struck with Astrazeneca last week looks pretty tasty.

[alloa2003] 02/4/2020 09:40

Big Pharma can be a nightmare - mess you about, close down anything which competes with them, etc. I remember years ago a supposed cure for tobacco addiction. Company was bought out indirectly by a cigarette company at an early stage and closed down.

[the stigologist] 01/4/2020 13:14

Can be a poisoned chalice working with Big Pharma.

[timberwolf3] 01/4/2020 12:41

I found the link between Craig Fox and Astra's Ian Scott interesting especially when you look at Scott's job description as project leader in Translational science:

High calibre scientific leader in drug discovery research with excellent track record in translating innovative science into projects, new business opportunities, scientific publications and intellectual property.

More than 15 years experience in leading global pharmaceutical and biotechnology companies.

In depth knowledge of small molecule and biological drug discovery processes.

Proven leadership skills in team, project, collaboration and operational management.

Flair for interpretation of complex scientific information and utilisation to drive projects.

Outstanding academic research background and high impact scientific publication record.

High quality scientific writing, drug discovery documentation and presentation skills

Cutting edge skills in cell, tissue and molecular biology, pharmacology, bioinformatics, in vivo model design/analysis and data handling.

Specialist knowledge of inflammation, tissue development, repair and remodelling, fibrosis, musculoskeletal and respiratory disease areas.

Experienced drug discovery translational research scientist, supporting biomarker development, patient selection and clinical development.

[davemac3] 01/4/2020 12:05

could be because they worked together a few years ago